[go: up one dir, main page]

UY37502A - CYCLIC DINUCLEOTIDE - Google Patents

CYCLIC DINUCLEOTIDE

Info

Publication number
UY37502A
UY37502A UY0001037502A UY37502A UY37502A UY 37502 A UY37502 A UY 37502A UY 0001037502 A UY0001037502 A UY 0001037502A UY 37502 A UY37502 A UY 37502A UY 37502 A UY37502 A UY 37502A
Authority
UY
Uruguay
Prior art keywords
cyclic dinucleotide
present description
sting
compound
prophylaxis
Prior art date
Application number
UY0001037502A
Other languages
Spanish (es)
Inventor
Zenyu Shiokawa
Akito Shibuya
Yusuke Sasaki
Tsuneo Oda
Yasufumi Wada
Morihisa Saitoh
Taisuke Kato
Yayoi Yoshitomi
Tomohiro Seki
Yasuo Nakagawa
Masaki Seto
Masanori Okaniwa
Kosuke HIDAKA
Shumpei Murata
Atsutoshi Okabe
Michiyo Mochizuki
Scott Freeze Brian
Taisuke Tawaraishi
Yoshihisa Nakada
Yusuke Tominari
Masato Yoshikawa
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of UY37502A publication Critical patent/UY37502A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente descripción proporciona un compuesto que tiene actividad agonista de STING, que puede esperarse que sea útil como agente para la profilaxis o el tratamiento de enfermedades relacionadas con STING. La presente descripción se refiere a un compuesto representado por la fórmula I, donde cada símbolo es como se definió en la descripción, o una sal de este.The present description provides a compound that has STING agonist activity, which can be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases. The present description refers to a compound represented by formula I, where each symbol is as defined in the description, or a salt thereof.

UY0001037502A 2016-12-01 2017-11-30 CYCLIC DINUCLEOTIDE UY37502A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016234553 2016-12-01
JP2017107216A JP2018090562A (en) 2016-12-01 2017-05-30 Cyclic dinucleotide
US201762589300P 2017-11-21 2017-11-21

Publications (1)

Publication Number Publication Date
UY37502A true UY37502A (en) 2018-06-29

Family

ID=62565132

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037502A UY37502A (en) 2016-12-01 2017-11-30 CYCLIC DINUCLEOTIDE

Country Status (4)

Country Link
JP (1) JP2018090562A (en)
AR (1) AR110283A1 (en)
TW (1) TWI769195B (en)
UY (1) UY37502A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20170192A1 (en) * 2016-12-01 2019-01-30 Takeda Pharmaceuticals Co Cyclic dinucleotide
KR102567590B1 (en) * 2018-09-06 2023-08-17 다이이찌 산쿄 가부시키가이샤 Novel cyclic dinucleotide derivatives and their antibody drug conjugates
CN110511259B (en) * 2019-08-22 2022-08-16 陕西师范大学 Cyclic dinucleotide artificial metalloenzyme, preparation thereof and application thereof in catalyzing asymmetric Friedel-Crafts reaction
JPWO2022220019A1 (en) * 2021-04-16 2022-10-20

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016524593A (en) * 2013-04-29 2016-08-18 メモリアル スローン−ケタリング キャンサー センター Compositions and methods for altering second messenger signaling
PE20160080A1 (en) * 2013-05-18 2016-02-21 Aduro Biotech Inc COMPOSITIONS AND METHODS TO ACTIVATE THE SIGNALING THAT DEPENDS ON THE INTERFERON GENE STIMULATOR
CN107148424B (en) * 2014-12-16 2021-01-08 凯拉治疗股份公司 Cyclic dinucleotides for inducing cytokines
US10449211B2 (en) * 2015-03-10 2019-10-22 Aduro Biotech, Inc. Compositions and methods for activating “stimulator of interferon gene”—dependent signalling
EA034786B1 (en) * 2015-08-13 2020-03-20 Мерк Шарп И Доум Корп. Cyclic di-nucleotide compounds as sting agonists
EP3368072A4 (en) * 2015-10-28 2019-07-03 Aduro BioTech, Inc. COMPOSITIONS AND METHODS FOR ACTIVATION OF DEPENDENT SIGNALING OF "INTERFERON GENE STIMULATOR"
NZ746112A (en) * 2016-03-18 2023-01-27 Immune Sensor Llc Cyclic di-nucleotide compounds and methods of use

Also Published As

Publication number Publication date
TW201825509A (en) 2018-07-16
TWI769195B (en) 2022-07-01
JP2018090562A (en) 2018-06-14
AR110283A1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
ECSP19046507A (en) CYCLIC DINUCLEOTIDES AS STING AGONISTS (INTERFERON GENES STIMULATOR)
CO2020006523A2 (en) Sting modulating compounds and methods of manufacture and use
MX2013006113A (en) Bicyclic compound.
UY35821A (en) HETEROCYCLIC COMPOUND
CL2019000844A1 (en) Pyridine compound
DOP2016000085A (en) AMINO-HETEROARIL-BENZAMIDAS AS CINASA INHIBITORS
DOP2015000140A (en) HETEROCYCLIC COMPOUND
CO7141410A2 (en) Nitrogenous heterocyclic compound
CO2019012125A2 (en) Ip6k inhibitors
CO2017003699A2 (en) Heterocyclic compound
BR112017011422A2 (en) hydroxamic isoazole acid compounds as lpxc inhibitors
AR102790A1 (en) ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS TO TREAT FOOD AND SURFACE PRODUCTS
ECSP17010238A (en) NOVELTY PYRIMIDINE COMPOUNDS REPLACED
CO2017001506A2 (en) Novel substituted pyrimidine compounds
BR112018075736A2 (en) benzotriazole-derived unsaturated alpha and beta amide compound used as tgf-betar inhibitor1
AR128158A2 (en) HETEROCYCLIC COMPOUND
UY35774A (en) HETEROCYCLIC COMPOUND
BR112017013286A2 (en) isoxazoline compound, and use of an isoxazoline compound.
UY37502A (en) CYCLIC DINUCLEOTIDE
MX2017010654A (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders.
DOP2013000051A (en) HETEROCICLICAL COMPOUNDS AND THEIR USES
MX2016015106A (en) DERIVATIVES OF DIPICOLILAMINE AND ITS PHARMACEUTICAL USES.
UY35650A (en) HETEROCYCLIC COMPOUND
MX2017001907A (en) Composition comprising arthropod eggs.
MX2017004632A (en) Improvements in and relating to water treatment, in particular to inhibit growth of micro-organisms.

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20201204